Literature DB >> 7340503

Naltrexone: a short-term treatment for opiate dependence.

R A Greenstein, C P O'Brien, A T McLellan, G E Woody, J Grabowski, M Long, G Coyle-Perkins, A Vittor.   

Abstract

The narcotic antagonist, naltrexone, was studied in 242 patients during a 6-year period. Although a large number of subjects discontinued naltrexone abruptly, treatment was related to a significant decrease in opiate and nonopiate drug use. Methods for improving retention during induction and maintenance are discussed and posttreatment outcome results are presented. The authors conclude that naltrexone may be a useful short-term treatment option for opiate dependence.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340503     DOI: 10.3109/00952998109009554

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  5 in total

1.  The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters.

Authors:  Hannah K Knudsen; Lori J Ducharme; Paul M Roman
Journal:  Drug Alcohol Depend       Date:  2006-09-12       Impact factor: 4.492

Review 2.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

3.  Long-acting injectable naltrexone for the management of patients with opioid dependence.

Authors:  Kimberly L Kjome; F Gerard Moeller
Journal:  Subst Abuse       Date:  2011-02-06

4.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06

5.  Naltrexone: A History and Future Directions.

Authors:  A Benjamin Srivastava; Mark S Gold
Journal:  Cerebrum       Date:  2018-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.